The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
Abstract
To define predictors of survival time in late human immunodeficiency virus type 1 (HIV-1) disease, long- and short-duration survivors were studied after their CD4+ T cells fell to </=50/mm3. Immune activation of CD4+ and CD8+ T cells, as measured by elevated cell surface expression of CD38 antigen, was strongly associated with shorter subsequent survival (P</=.002). The naive CD45RA+CD62L+ T cell reserve was low in all subjects and did not predict survival (P=.34 for CD4+ and.08 for CD8+ cells). Higher virus burden correlated with CD8+ but not CD4+ cell activation and, after correcting for multiple comparisons, was not associated with shorter survival (P=.02). All of the patients' viruses used CCR5, CXCR4, or both, and coreceptor usage did not predict survival (P=. 27). Through mechanisms apparently unrelated to higher virus burden, immune activation is a major determinant of survival in advanced HIV-1 disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
Nonparametrics: Statistical Methods Based on Ranks
Mergenthaler, M. J., & Lehmann, E. L. (1979) · Technometrics · doi:10.2307/1268531 · Cited by 3,329
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Self-citationNonparametrics: Statistical Methods Based on Ranks.
Beaver, R. J., & Lehmann, E. L. (1976) · Biometrics · doi:10.2307/2529529 · Cited by 2,047
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
Manual of Clinical Laboratory Immunology
Rose, N. R., Hamilton, R. G., & Detrick, B. (1992) · Cited by 1,250
KASLOW, R. A., OSTROW, D. G., DETELS, R., PHAIR, J. P., POLK, B. F., RINALDO, C. R., & STUDY, F. T. M. A. C. (1987) · American Journal of Epidemiology · doi:10.1093/aje/126.2.310 · Cited by 1,194
Self-citationThe HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., & Mackay, C. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1925 · Cited by 1,134
Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., de Goede, R. E., van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F., & Tersmette, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1354-1360.1992 · Cited by 1,032
Fahey, J. L., Taylor, J. M. G., Detels, R., Hofmann, B., Melmed, R., Nishanian, P., & Giorgi, J. V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220305 · Cited by 1,023
Self-citationFinkel, T. H., Tudor-Williams, G., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C., Baba, T. W., Ruprecht, R. M., & Kupfer, A. (1995) · Nature Medicine · doi:10.1038/nm0295-129 · Cited by 947
Groux, H., Torpier, G., Monté, D., Mouton, Y., Capron, A., & Ameisen, J. C. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.331 · Cited by 881
Koot, M., Keet, I. P. M., Vos, A. H. V., de Goede, R. E. Y., Roos, M. T. L., Coutinho, R. A., Miedema, F., Schellekens, P. T. A., & Tersmette, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00004 · Cited by 785
Fouchier, R. A., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., Miedema, F., & Schuitemaker, H. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3183-3187.1992 · Cited by 770
Detels, R. (1998) · JAMA · doi:10.1001/jama.280.17.1497 · Cited by 739
Self-citationLane, H. C., Depper, J. M., Greene, W. C., Whalen, G., Waldmann, T. A., & Fauci, A. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130204 · Cited by 728
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
Scarlatti, G., Tresoldi, E., Björndal, Å., Fredriksson, R., Colognesi, C., Kui Deng, H., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., et al. (1997) · Nature Medicine · doi:10.1038/nm1197-1259 · Cited by 633
Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S., & Shearer, G. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114376 · Cited by 613
Björndal, A., Deng, H., Jansson, M., Fiore, J. R., Colognesi, C., Karlsson, A., Albert, J., Scarlatti, G., Littman, D. R., & Fenyö, E. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7478-7487.1997 · Cited by 606
Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection
Wolinsky, S. M., Korber, B. T. M., Neumann, A. U., Daniels, M., Kunstman, K. J., Whetsell, A. J., Furtado, M. R., Cao, Y., Ho, D. D., Safrit, J. T., et al. (1996) · Science · doi:10.1126/science.272.5261.537 · Cited by 567
Self-citationLiu, Z., Cumberland, W. G., Hultin, L. E., Prince, H. E., Detels, R., & Giorgi, J. V. (1997) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199710010-00003 · Cited by 546
Self-citationConnors, M., Kovacs, J. A., Krevat, S., Gea-Banacloche, J. C., Sneller, M. C., Flanigan, M., Metcalf, J. A., Walker, R. E., Falloon, J., Baseler, M., et al. (1997) · Nature Medicine · doi:10.1038/nm0597-533 · Cited by 515
Immunopathogenic Mechanisms of HIV Infection
Fauci, A. S., Pantaleo, G., Stanley, S., & Weissman, D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00006 · Cited by 512
CD8 naive T cell counts decrease progressively in HIV-infected adults.
Roederer, M., Dubs, J. G., Anderson, M. T., Raju, P. A., Herzenberg, L. A., & Herzenberg, L. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117892 · Cited by 489
Effros, R. B., Allsopp, R., Chiu, C.-P., Hausner, M. A., Hirji, K., Wang, L., Harley, C. B., Villeponteau, B., West, M. D., & Giorgi, J. V. (1996) · AIDS · doi:10.1097/00002030-199607000-00001 · Cited by 457
Self-citationGiorgi, J. V., Liu, Z., Hultin, L. E., Cumberland, W. G., Hennessey, K. A., & Detels, R. (1993) · PubMed · Cited by 443
Self-citationLederman, M. M., Connick, E., Landay, A., Kuritzkes, D. R., Spritzler, J., St. Clair, M., Kotzin, B. L., Fox, L., Heath Chiozzi, M., Leonard, J. M., et al. (1998) · Journal of Infectious Diseases · doi:10.1086/515591 · Cited by 425
Richman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
Human CD38: a glycoprotein in search of a function
Malavasi, F., Funaro, A., Roggero, S., Horenstein, A., Calosso, L., & Mehta, K. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90148-1 · Cited by 345
Activation of virus replication after vaccination of HIV-1-infected individuals.
Staprans, S. I., Hamilton, B. L., Follansbee, S. E., Elbeik, T., Barbosa, P., Grant, R. M., & Feinberg, M. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1727 · Cited by 318
CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use.
Taylor, J. M. G., Fahey, J. L., Detels, R., & Giorgi, J. V. (1989) · PubMed · Cited by 306
Self-citationO'Brien, W., Grovit-Ferbas, K., Namazi, A., Ovcak-Derzic, S., Wang, H., Park, J., Yeramian, C., Mao, S., & Zack, J. (1995) · Blood · doi:10.1182/blood.v86.3.1082.1082 · Cited by 304
T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4 + T Cell Turnover
Wolthers, K. C., Bea, G., Wisman, A., Otto, S. A., de Roda Husman, A.-M., Schaft, N., de Wolf, F., Goudsmit, J., Coutinho, R. A., van der Zee, A. G. J., et al. (1996) · Science · doi:10.1126/science.274.5292.1543 · Cited by 286
Liu, Z., Cumberland, W. G., Hultin, L. E., Kaplan, A. H., Detels, R., & Giorgi, J. V. (1998) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199808010-00004 · Cited by 237
Self-citationGiorgi, J. V., Cheng, H.-L., Margolick, J. B., Bauer, K. D., Ferbas, J., Waxdal, M., Schmid, I., Hultin, L. E., Jackson, A. L., Park, L., et al. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90096-9 · Cited by 232
Self-citationCirculating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens
Ho, H. N., Hultin, L. E., Mitsuyasu, R. T., Matud, J. L., Hausner, M. A., Bockstoce, D., Chou, C. C., O’Rourke, S., Taylor, J. M., & Giorgi, J. V. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.3070 · Cited by 227
Self-citationSchmid, I., Uittenbogaart, C. H., & Giorgi, J. V. (1994) · Cytometry · doi:10.1002/cyto.990150104 · Cited by 221
Self-citationPantaleo, G., Soudeyns, H., Demarest, J. F., Vaccarezza, M., Graziosi, C., Paolucci, S., Daucher, M., Cohen, O. J., Denis, F., Biddison, W. E., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9848 · Cited by 201
Giorgi, J. V., Ho, H.-N., Hirji, K., Chou, C.-C., Hultin, L. E., O'Rourke, S., Park, L., Margolick, J. B., Ferbas, J., Phair, J. P., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.4.775 · Cited by 188
Self-citationCHMIEL, J. S., DETELS, R., KASLOW, R. A., VAN RADEN, M., KINGSLEY, L. A., BROOKMEYER, R., & THE MULTICENTER AIDS COHORT STUDY GROUP (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114696 · Cited by 184
Self-citationbofill, M., mocroft, A., lipman, M., Medina, E., Borthwick, N. J., Sabin, C. A., Timms, A., Winter, M., Baptista, L., Johnson, M. A., et al. (1996) · AIDS · doi:10.1097/00002030-199607000-00005 · Cited by 181
Inhibition of HIV-1 Infection by the b-Chemokine MDC
Pal, R., Demo, A. G., Markham, P. D., et al. (2016) · Cited by 176
Inhibition of HIV-1 Infection by the β-Chemokine MDC
Pal, R., Garzino-Demo, A., Markham, P. D., Burns, J., Brown, M., Gallo, R. C., & DeVico, A. L. (1997) · Science · doi:10.1126/science.278.5338.695 · Cited by 175
KESTENS, L., VANHAM, G., VEREECKEN, C., VANDENBRUAENE, M., VERCAUTEREN, G., COLEBUNDERS, R. L., & GIGASE, P. L. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb07015.x · Cited by 174
Cytokine modulation of HIV expression
Poli, G., & Fauci, A. S. (1993) · Seminars in Immunology · doi:10.1006/smim.1993.1020 · Cited by 145
Schellekens, P. T. A., Roos, M. T. L., de Wolf, F., Lange, J. M. A., & Miedema, F. F. (1990) · Journal of Clinical Immunology · doi:10.1007/bf00918194 · Cited by 105
Hultin, L. E., Matud, J. L., & Giorgi, J. V. (1998) · Cytometry · Cited by 82
Self-citationThree-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection.
Prince, H., & Jensen, E. R. (1991) · PubMed · Cited by 72
Estimation of time since exposure for a prevalent cohort
Muñoz, Á., Carey, V. J., Taylor, J. M. G., Chmiel, J. S., Kingsley, L., Raden, M. V., & Hoover, D. R. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110711 · Cited by 51
Lynne, J. E., Schmid, I., Matud, J. L., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/517400 · Cited by 47
Yagi, M. J., Chu, F.-N., Jiang, J. D., Wallace, J. I., Mason, P., Liu, Y., Carafa, J., & Bekesi, J. G. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90004-8 · Cited by 32
Phenotype and Function of T Cells in HIV Disease
Giorgi, J. V. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0191-0_9 · Cited by 18
Self-citation
Cited by
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq118 · Cited by 1,106
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Immune activation and inflammation in HIV‐1 infection: causes and consequences
Appay, V, & Sauce, D. (2008) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 743
Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
Vujkovic-Cvijin, I., Dunham, R. M., Iwai, S., Maher, M. C., Albright, R. G., Broadhurst, M. J., Hernandez, R. D., Lederman, M. M., Huang, Y., Somsouk, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006438 · Cited by 738
Metadata
- Authors
- Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., Wolinsky, S. M., & Detels, R.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04
- Volume
- 179
- Issue
- 4
- Pages
- 859-870
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2127031590
- Cited by
- 1,033
- References
- 59
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.